Most mole biopsies are benign, says text analysis of EMRs
UW Medicine News Dec 05, 2017
The great majority of biopsied moles pose no danger, according to an analysis of 80,000 skin samples that employed natural language processing (NLP) software to glean patient data and generate population-level estimates of diagnoses.
The novel approach demonstrates that text-analysis tools can, with high accuracy and far faster than human annotators, harvest and interpret physicians’ reports to yield context about the prevalence and incidence of medical conditions.
The findings were published in the journal JAMA Dermatology.
The multi-site investigation involved Drs. Michael Piepkorn and Joann Elmore, faculty physicians at the University of Washington School of Medicine. Elmore is also an epidemiologist with the UW School of Public Health.
“There’s a wealth of information in electronic medical records that has been untapped for population-level studies like this,” Elmore said. “Text-analysis software is especially helpful to decipher pathologists’ reports, because they have a wide array of terms for the same type of lesion.”
The investigators were interested to identify the portion of biopsied skin lesions that were melanocytic—the type that can develop into malignant melanoma.
On the basis of 289 original pathology reports, the researchers designed search strings to recognize and differentiate diagnostic terms, phrases and their derivations, and neighboring context so that pathologists’ intended linguistic meanings were construed accurately in the subsequent scan of electronic medical records.
That search comprised 80,368 biopsy diagnoses from more than 47,000 patients in the Group Health Cooperative healthcare system (now Kaiser Permanente) in Washington state between January 2007 and December 2012.
Melanocytic lesions accounted for 23% of all diagnoses, a portion that surprised Elmore.
“I was shocked. I thought it’d be only 5% or 10%,” she said, quickly adding that most melanocytic cells were characterized as benign.
The melanocytic diagnoses were stratified into four risk classes:
- Class I: Nevi and other benign proliferations (83%)
- Class II: Moderately dysplastic and other low-risk lesions (8.3%)
- Class III: Melanoma in-situ and other higher-risk lesions (4.5%)
- Class IV/V: Invasive melanoma (4.1%)
Pathologists also use a “striking array of subjective terms” when interpreting the same melanocytic lesion, the investigators noted, despite repeated calls for national guidelines on precise, consistent wording of the gray-area diagnoses between benign and malignant.
Natural language software is not flawless but has been used to reliably gather details from electronic medical records and found to perform as well as, or better than, manual record review by human annotators.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data
Sign up with M3 India to try daily quizzes and take part in competitionsTry M3 India / Log In
Why join our Market Research Panel?
- 10K+ Doctors participated in 40+ Indian and Global studies in 2018
- Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor